Industry Discovery & Development Partnership
Breakthrough T1D's IDDP program funds for-profit companies developing innovative therapies or devices to treat, cure, or prevent type 1 diabetes, supporting projects with strong scientific and commercial potential.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and proposals accepted year-round)
Funding Amounts: Flexible; award amount and duration as approved, typically requires matching funds from company.
Summary: Supports for-profit organizations advancing research projects in priority areas of type 1 diabetes with strong commercial and therapeutic potential.
Key Information: LOIs must be discussed with Breakthrough T1D staff prior to submission; company match required.
Description
The Industry Discovery & Development Partnership (IDDP) program from Breakthrough T1D provides funding and collaborative support to for-profit companies—including biotech, pharmaceutical, and device firms—working on research projects that align with Breakthrough T1D’s priority research areas. The program is designed to accelerate the discovery, development, and commercialization of therapies and devices for the treatment, cure, and prevention of type 1 diabetes (T1D). Projects must have clear commercial potential and a strong alignment with Breakthrough T1D’s mission. The program fosters long-term collaborations between industry and Breakthrough T1D, leveraging each party’s strengths to advance impactful T1D products.
